We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

121 hedge funds and large institutions have $245M invested in Arena Pharmaceuticals Inc in 2015 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more call options, than puts

Call options by funds: $3.07M | Put options by funds: $1.97M

11% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 19

3% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 35

1% more funds holding

Funds holding: 120 → 121 (+1)

8% less capital invested

Capital invested by funds: $267M → $245M (-$21.5M)

Holders
121
Holders Change
+1
Holders Change %
+0.83%
% of All Funds
3.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
36
Reduced
35
Closed
19
Calls
$3.07M
Puts
$1.97M
Net Calls
+$1.1M
Net Calls Change
-$94K

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$17.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.91M
3
Millennium Management
Millennium Management
New York
+$2.68M
4
Renaissance Technologies
Renaissance Technologies
New York
+$2.09M
5
AC
Ascend Capital
California
+$1.68M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$18.1M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$9.43M
3
State Street
State Street
Massachusetts
-$9.34M
4
DM
Deerfield Management
New York
-$8.86M
5
Ameriprise
Ameriprise
Minnesota
-$1.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$852K +$16.3K +798 +2%
DCM
27
DAFNA Capital Management
California
$725K – – –
UBS Group
28
UBS Group
Switzerland
$721K +$684K +33,554 +767%
AIG
29
American International Group
New York
$674K -$63.9K -3,132 -8%
TA
30
Teachers Advisors
New York
$667K – – –
USAA
31
United Services Automobile Association
Texas
$664K – – –
VEA
32
Virtus ETF Advisers
New York
$614K +$659K +32,311 New
Swiss National Bank
33
Swiss National Bank
Switzerland
$593K – – –
QI
34
QS Investors
New York
$588K – – –
Citadel Advisors
35
Citadel Advisors
Florida
$545K -$1.03M -50,526 -64%
Goldman Sachs
36
Goldman Sachs
New York
$531K -$370K -18,134 -39%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$470K +$42.8K +2,098 +9%
ProShare Advisors
38
ProShare Advisors
Maryland
$438K +$45.8K +2,244 +11%
Cambridge Investment Research Advisors
39
Cambridge Investment Research Advisors
Iowa
$421K +$452K +22,153 New
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$420K – – –
CS
41
Credit Suisse
Switzerland
$379K -$85.5K -4,192 -17%
State Board of Administration of Florida Retirement System
42
State Board of Administration of Florida Retirement System
Florida
$378K – – –
Connor, Clark & Lunn Investment Management (CC&L)
43
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$375K +$68.5K +3,360 +20%
BG
44
BlackRock Group
United Kingdom
$345K -$4.53K -222 -1%
MLICM
45
Metropolitan Life Insurance Company (MetLife)
New York
$327K +$2.83K +139 +0.8%
Deutsche Bank
46
Deutsche Bank
Germany
$308K -$564K -27,634 -63%
NFA
47
Nationwide Fund Advisors
Ohio
$303K +$4.67K +229 +1%
Squarepoint
48
Squarepoint
New York
$240K +$257K +12,620 New
DekaBank Deutsche Girozentrale
49
DekaBank Deutsche Girozentrale
Germany
$239K +$2.04K +100 +0.8%
UBS AM
50
UBS AM
Illinois
$235K – – –
1
2
3 4 5

ARNA Hedge Fund Activity: Q4 2015 in Review

121 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q4 2015, worth a combined $245M — down 8.1% from $267M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new ARNA positions and 19 closed out — a net gain of 2 holders — while 36 added to existing stakes and 35 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $17.8M. The largest seller was Wellington Management Group, cutting an estimated $18.1M.

  • 121 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q4 2015, up from 120 in Q3 2015.
  • Funds reported $245M of Arena Pharmaceuticals Inc stock for Q4 2015, down 8.1% quarter-over-quarter.
  • 21 funds opened new Arena Pharmaceuticals Inc positions in Q4 2015 and 19 closed out, a net change of +2 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q4 2015 was RA Capital Management, an estimated $17.8M added.
  • The largest Arena Pharmaceuticals Inc seller in Q4 2015 was Wellington Management Group, an estimated $18.1M sold.

Based on aggregated 13F filings for Q4 2015.